NASDAQ: VRAX
Virax Biolabs Group Ltd Stock Ownership - Who owns Virax Biolabs Group?

Insider buying vs selling

Have Virax Biolabs Group Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when VRAX insiders and whales buy or sell their stock.

VRAX Shareholders

What type of owners hold Virax Biolabs Group Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Alexander Cunliffe Foster4.40%287,987$38.88kInsider
Xtx Topco Ltd0.33%21,437$2.89kInstitution
Ubs Group Ag0.11%7,492$1.01kInstitution
National Bank Of Canada0.09%6,000$810.00Institution
Farther Finance Advisors LLC0.00%21$2.84Institution
Osaic Holdings Inc0.00%20$2.70Institution
Northwestern Mutual Wealth Management Co0.00%10$1.35Institution

1 of 1

VRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRAX0.53%4.40%
CMND0.44%0.00%
ASBP48.63%51.37%Net Buying
ONCO1.03%98.97%Net BuyingNet Buying
PHGE0.96%99.04%Net SellingNet Selling

Virax Biolabs Group Stock Ownership FAQ

Who owns Virax Biolabs Group?

Virax Biolabs Group (NASDAQ: VRAX) is owned by 0.53% institutional shareholders, 4.40% Virax Biolabs Group insiders, and 95.06% retail investors. James Alexander Cunliffe Foster is the largest individual Virax Biolabs Group shareholder, owning 287,987.00 shares representing 4.40% of the company. James Alexander Cunliffe Foster's Virax Biolabs Group shares are currently valued at $38.59k.

If you're new to stock investing, here's how to buy Virax Biolabs Group stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.